1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Effects of aspirin on distortion product fine structure: Interpreted by the two-source model for distortion product otoacoustic emissions generation
Rent:
Rent this article for
USD
10.1121/1.3523308
/content/asa/journal/jasa/129/2/10.1121/1.3523308
http://aip.metastore.ingenta.com/content/asa/journal/jasa/129/2/10.1121/1.3523308

Figures

Image of FIG. 1.
FIG. 1.

Changes in DP fine structure before, during, and after aspirin consumption for subject 1 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (A) and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries (C), higher-frequency, high-level primaries (B), and higher-frequency, low-level primaries (D).

Image of FIG. 2.
FIG. 2.

Changes in the levels of maxima and minima before, during, and after aspirin consumption for subject 1 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (A) and higher-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (B).

Image of FIG. 3.
FIG. 3.

Changes in DP fine structure seen with aspirin consumption for subject 3 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (A) and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries (C), higher-frequency, high-level primaries at high level (B), and high-frequency, low-level primaries (D).

Image of FIG. 4.
FIG. 4.

Changes in levels of maxima and minima seen with aspirin consumption for subject 3 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (A) and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries (C), higher-frequency, high-level primaries (B), and higher-frequency, low-level primaries (D).

Image of FIG. 5.
FIG. 5.

Changes in nonlinear and reflection components during aspirin consumption for subject 1 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries [(A) and (C)] and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries [(E) and (G)], higher-frequency, high-level primaries [(B) and (D)], higher-frequency, low-level primaries [(F) and (H)].

Image of FIG. 6.
FIG. 6.

Changes in nonlinear and reflection components seen with aspirin consumption for subject 3 for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries [(A) and (C)] and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries [(E) and (G)], higher-frequency, high-level primaries [(B) and (D)], higher-frequency, low-level primaries [(F) and (H)].

Image of FIG. 7.
FIG. 7.

Changes in the average nonlinear and reflection components with aspirin consumption for subjects 1 (solid symbols and lines) and 3 (open symbols and dashed lines) for lower-frequency, high-level (f 1 = 70 dB SPL, f 2 = 60 dB SPL) primaries (A) and lower-frequency, low-level (f 1 = 55 dB SPL, f 2 = 40 dB SPL) primaries (C), higher-frequency, high-levels primaries (B), and higher-frequency, low-level primaries (D).

Tables

Generic image for table
TABLE I.

Frequency ranges used for DPOAE recordings for all three subjects. Note that the lower-frequency range for subject 3 overlaps with the higher-frequency range for subject 1.

Loading

Article metrics loading...

/content/asa/journal/jasa/129/2/10.1121/1.3523308
2011-02-24
2014-04-18
Loading

Full text loading...

This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Effects of aspirin on distortion product fine structure: Interpreted by the two-source model for distortion product otoacoustic emissions generation
http://aip.metastore.ingenta.com/content/asa/journal/jasa/129/2/10.1121/1.3523308
10.1121/1.3523308
SEARCH_EXPAND_ITEM